HIV and Associated TB: A Lethal Association for Kidney Health?
Robert Kalyesubula1, Nicola Wearne2, Mary Kubo3
1Department of Physiology and Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Human immunodeficiency virus (HIV) and tuberculosis (TB) coinfection significantly impacts kidney health, particularly in low-income nations. Effective management strategies are crucial to mitigate kidney disease progression and improve patient outcomes.
Area of Science:
- Global health
- Infectious diseases
- Nephrology
Background:
- Human immunodeficiency virus (HIV) and tuberculosis (TB) are leading global infectious causes of mortality.
- HIV/TB coinfection disproportionately affects low- and middle-income countries, causing severe kidney damage and accelerated decline in kidney function.
- Managing the complex interplay of TB, HIV, and kidney disease presents significant clinical challenges.
Purpose of the Study:
- To review the epidemiology of HIV/TB coinfection and its impact on kidney disease.
- To explore the mechanisms, clinical presentation, and diagnostic challenges of kidney disease in coinfected patients.
- To outline prevention and management strategies for HIV/TB-related kidney disease.
Main Methods:
- Literature review and synthesis of existing research on HIV/TB coinfection and kidney disease.
- Discussion of epidemiological data, pathogenic mechanisms, and clinical manifestations.
- Exploration of diagnostic hurdles and therapeutic interventions.
Main Results:
- HIV/TB coinfection accelerates kidney function decline and increases mortality.
- Genetic susceptibility plays a role in HIV/TB-related kidney disease.
- Challenges exist in diagnosing chronic kidney disease (CKD) in this population.
Conclusions:
- HIV/TB coinfection elevates kidney-related morbidity and mortality risks.
- Special consideration for research and management is imperative for patients with HIV/TB coinfection and kidney disease.
- Preventive measures include careful assessment, avoiding nephrotoxic drugs, dose adjustments, and monitoring.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Sexually Transmitted Infections
